Alx Oncology Holdings (ALXO) Return on Sales (2019 - 2021)

Alx Oncology Holdings (ALXO) has 3 years of Return on Sales data on file, last reported at 1.03% in Q1 2021.

• For the quarter ending Q1 2021, Return on Sales fell 95.0% year-over-year to 1.03%; the trailing twelve-month figure through Mar 2021 stood at 1.03% (down 103.0% YoY), and the FY2020 full-year result was 0.39%, down 39.0% from the prior year.
• Return on Sales slipped to 1.03% in Q1 2021, from 0.39% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.1% in Q4 2019 to a low of 1.03% in Q1 2021.
• A 3-year average of 0.22% and a median of 0.07% in 2020 frame the typical range for Return on Sales.
• Across the five-year window, Return on Sales fell 4 bps in 2020 and tumbled 95 bps in 2021, its largest moves.
• Tracing ALXO's Return on Sales over 3 years: stood at 0.1% in 2019, then slumped by 483 bps to 0.39% in 2020, then sank by 167 bps to 1.03% in 2021.
• Business Quant data shows ALXO's Return on Sales at 1.03% in Q1 2021, 0.39% in Q4 2020, and 0.06% in Q3 2020.